Development
Evaxion Biotech A/S
EVAX
$3.13
$0.5521.32%
NASDAQ
| 09/30/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.61M | 7.12M | 13.18M | -- | |
| Total Receivables | 781.00K | 917.00K | 1.31M | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 3.35M | 3.33M | 2.49M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 117.00K | -- | -- | -- | |
| Total Current Assets | 6.85M | 11.37M | 16.99M | -- | |
|
|
|||||
| Total Current Assets | 6.85M | 11.37M | 16.99M | -- | |
| Net Property, Plant & Equipment | 4.31M | 4.58M | 4.68M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 777.00K | 804.00K | 365.00K | -- | |
| Total Assets | 11.94M | 16.75M | 22.03M | -- | |
|
|
|||||
| Total Accounts Payable | 2.61M | 1.69M | 2.09M | -- | |
| Total Accrued Expenses | -- | -- | 353.00K | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 461.00K | 470.00K | 439.00K | -- | |
| Total Finance Division Other Current Liabilities | 1.62M | 1.90M | 885.00K | -- | |
| Total Other Current Liabilities | 1.62M | 1.90M | 885.00K | -- | |
| Total Current Liabilities | 4.69M | 4.05M | 3.76M | -- | |
|
|
|||||
| Total Current Liabilities | 4.69M | 4.05M | 3.76M | -- | |
| Long-Term Debt | 7.99M | 8.08M | 7.86M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 1.86M | 1.95M | 1.95M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 143.00K | 147.00K | 144.00K | -- | |
| Total Liabilities | 14.68M | 14.22M | 13.72M | -- | |
|
|
|||||
| Common Stock & APIC | 90.56M | 90.41M | 84.61M | -- | |
| Retained Earnings | -89.76M | -84.26M | -72.66M | -- | |
| Treasury Stock & Other | -3.53M | -3.62M | -3.65M | -- | |
| Total Common Equity | -2.73M | 2.54M | 8.30M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -2.73M | 2.54M | 8.30M | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -2.73M | 2.54M | 8.30M | -- | |
|
|
|||||